Laxmi Organic Industries LimitedQ1 FY27 Results & Financial Update
Laxmi Organic Industries Limited: Q1 FY27 consolidated results and company financials – revenue ₹968.34 Cr, PAT ₹67.72 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Find an answer
Ask this result
Chart · Market context
Laxmi Organic Industries price & chart
Quarter overview
Quarterly earnings analysis
For the first quarter of fiscal year 2027 (ended June 30, 2026), Laxmi Organic Industries reported consolidated revenue from operations of INR 968.34 crore, alongside total income of INR 971.78 crore.
Profit before tax (PBT) for the quarter stood at INR 91.76 crore, reflecting solid operational momentum across the chemical business segment.
Profit after tax (PAT) reached INR 67.71 crore, delivering a PAT margin of approximately 6.99% on consolidated revenue.
Basic and diluted earnings per share (EPS) for the quarter were recorded at INR 2.44 on a face value of INR 2 per equity share.
The company's performance was underpinned by sequential recovery in operating scale, though tax expenses reflected changes under the updated income tax regulations.
Total consolidated expenses for the quarter were maintained at INR 880.02 crore, with raw material consumption and power costs forming the bulk of operational expenditures.
The board of directors approved the financial results during their meeting held on July 29, 2026, following review by the audit committee and statutory auditors.
For the quarter ended June 30, 2026 (Q1 FY27), Laxmi Organic Industries reported consolidated revenue from operations of INR 9,683.38 million, accompanied by other income of INR 34.39 million, bringing total consolidated income to INR 9,717.77 million.
01 · Business model
What does Laxmi Organic Industries do?
Laxmi Organic Industries Limited operates as a leading specialty chemical manufacturer with a diversified portfolio spanning acetyl intermediates and specialty intermediates.
The company serves global and domestic customer bases across various end-user industries including pharmaceuticals, agrochemicals, dyes, pigments, and packaging.
Manufacturing operations are anchored by key production facilities situated in Maharashtra, backed by subsidiaries and global entities across Europe, China, and specialized life science ventures.
02 · Historical context
What shaped the business before this quarter
During Q1 FY25, the company moved to the new tax regime under Section 115BAA, subsequently reverted to the old tax regime in Q4 FY26 following Union Budget amendments to utilize MAT credit, and then exercised the option under Section 200 of the Income-tax Act, 2025 (corresponding to Section 115BAA) at a 25.17% tax rate effective from Q1 FY27.
During the previous year ended March 31, 2026, the company recognized INR 38.02 million as a statutory impact towards additional gratuity liability and compensated absences resulting from the notification of the new Labour Codes.
03 · Financial snapshot
Current-quarter financial snapshot
| Metric | Q1 FY27 |
|---|---|
| Revenue from operations | ₹968.34 Cr |
| Total income | ₹971.78 Cr |
| Profit before tax | ₹91.76 Cr |
| Profit after tax | ₹67.72 Cr |
| EPS | ₹2.44 |
Financial interpretation
What the reported numbers mean
Profit after tax represented 7.0% of reported quarterly operating revenue. This is a calculated net-profit-to-sales ratio, not a company-reported operating margin. It measures the outcome after expenses and tax; it does not, by itself, establish how margins changed versus another period.
Profit before tax was equivalent to 9.5% of quarterly operating revenue. The distinction between pre-tax and post-tax profit matters when interpreting earnings; neither ratio identifies an underlying cost driver without a properly matched comparative period.
Total income exceeded operating revenue by ₹3.44 crore. This is the disclosed difference between the two lines, not incremental sales. The distinction matters when assessing how much of the quarter’s reported income came from the operating top line.
Ratios above are calculated from the reported quarterly figures. They are analytical descriptions, not company-reported margin guidance or an investment recommendation.
04 · Why it moved
Why the quarter looked the way it did
What drove revenue
Reported at INR 968.34 crore for Q1 FY27, driven by active demand across core chemical product lines.
Contributed INR 3.44 crore to the consolidated top-line during the quarter.
Revenue from operations reached INR 9,683.38 million for Q1 FY27, complemented by INR 34.39 million of other income, driven by robust operational output across the chemical manufacturing footprint.
Consolidated performance incorporates contributions from active subsidiaries including Cellbion Lifesciences, Laxmi Organic Industries (Europe) B.V., Viva Lifesciences, Laxmi Speciality Chemicals (Shanghai), and Laxmi Italy SRL.
What drove margins
Cost of raw materials consumed stood at INR 617.54 crore, while power and fuel expenses accounted for INR 76.55 crore.
Effective tax expenses for the period reflect the company's election of the tax rate under section 200 of the Income-tax Act, 2025 (corresponding to section 115BAA), alongside utilization of brought-forward losses.
Cost of raw materials consumed was reported at INR 6,175.36 million, while purchases of stock-in-trade stood at INR 167.51 million for the quarter.
Power and fuel expenses accounted for INR 765.54 million, employee benefits expenses were INR 398.24 million, and other expenses aggregated to INR 1,319.52 million on a consolidated basis.
Depreciation and amortization expenses were recorded at INR 217.14 million, and finance costs stood at INR 42.96 million for the quarter.
05 · Segments, products & geography
Which parts of the business are doing the work
Segments and products
In accordance with Ind AS 108, the Chief Operating Decision Maker evaluates performance as a single operating segment named 'Chemical Business'.
06 · Reported developments
What changed operationally
The company allotted 63,694 equity shares of INR 2 each on April 3, 2026, to option grantees, raising the paid-up share capital to INR 55.44 crore.
07 · Beyond the numbers
What changed beyond the numbers
ESOP Allotment
During Q1 FY27, the company allotted 63,694 equity shares of face value INR 2 each on April 3, 2026, to option grantees, increasing paid-up capital from INR 554.30 million to INR 554.42 million.
08 · Key Q&A
The quarter, answered directly
What does Laxmi Organic Industries do?
Laxmi Organic Industries Limited operates as a leading specialty chemical manufacturer with a diversified portfolio spanning acetyl intermediates and specialty intermediates.
What is the clearest takeaway from Q1 FY27?
For the first quarter of fiscal year 2027 (ended June 30, 2026), Laxmi Organic Industries reported consolidated revenue from operations of INR 968.34 crore, alongside total income of INR 971.78 crore.
What drove revenue or demand?
Reported at INR 968.34 crore for Q1 FY27, driven by active demand across core chemical product lines.
What mattered most for margins or profitability?
Cost of raw materials consumed stood at INR 617.54 crore, while power and fuel expenses accounted for INR 76.55 crore.
What changed operationally beyond the headline numbers?
During Q1 FY27, the company allotted 63,694 equity shares of face value INR 2 each on April 3, 2026, to option grantees, increasing paid-up capital from INR 554.30 million to INR 554.42 million.
What should the next disclosure help confirm?
Monitor upcoming financial results and disclosures for continued margin trends and raw material cost fluctuations.
09 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
10 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Subsequent Quarterly Disclosures: Monitor upcoming financial results and disclosures for continued margin trends and raw material cost fluctuations.
- 02
Subsequent Financial Disclosures: Monitor upcoming quarterly financial disclosures for sequential revenue and margin trajectories under the newly adopted 25.17% tax regime.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.
